Federation des caisses Desjardins du Quebec’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.46K Sell
250
-6,682
-96% -$120K ﹤0.01% 2620
2026
Q1
$124K Sell
6,932
-993
-13% -$21.7K ﹤0.01% 1644
2025
Q4
$214K Buy
+7,925
New +$223K ﹤0.01% 1484

Other funds holding CAI

Federation des caisses Desjardins du Quebec's CAI Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Caris Life Sciences (CAI) stake by 96% in Q2 2026, selling an estimated $120K and leaving 250 shares worth $4.46K. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Federation des caisses Desjardins du Quebec first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $214K in Q4 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 250 shares of Caris Life Sciences worth $4.46K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec sold 6,682 Caris Life Sciences shares in Q2 2026, an estimated $120K.
  • Caris Life Sciences made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2620 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Federation des caisses Desjardins du Quebec's Caris Life Sciences position peaked at $214K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.